Rejected at 3:07 a.m. Nov, 01, 2023 ] by Ahmed7
Author: jiffypeople
Related Note: 1488855097679
Rationale for change

include renal teratogenicity as reason for contraindic
Source: UWorld - Step 2 4050

Rejection reason

stated in extra (renal dysfunction)

Text Text
Extra
- Especially with indomethacin and ibuprofen

- AMBOSS states it is contraindicated in 2nd trimester as well

- Can cause other complications as well (e.g., spontaneous abortion, inhibition of uterine contractility, oligohydramnios, renal dysfunction)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch NSAIDs
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize



Physeo

Bootcamp
Watch associated Bootcamp video - Platelets : Antiplatelet Medications

Watch associated Bootcamp video - Pharmacology : NASIDs

Watch associated Bootcamp video - Fetal Development : Teratogenic Medications
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::03_NSAIDs #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::05_NSAIDs #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::01_Normal_Pregnancy::Extra #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::05_Nonsteroidal_anti-inflammatory_drugs #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::01_NSAIDs #PANCE::EOR::PEDS !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::CARDIO::congenital_heart_disease #AK_Step1_v12::#Bootcamp::Reproduction::01_Fetal_Development::03_Teratogenic_Medications #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::04_NSAIDs #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#OME::PreClinical::Musculoskeletal #AK_Step1_v12::^Systems::Musculoskeletal::Pharmacology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::05_Antiplatelet_Medications